Robert Wilbur, Pharm.D., CPh. | Executive Director, Medical Affairs
Robert received his Bachelors of Science degree from the University of South Florida, Doctorate of Pharmacy degree from Mercer University, and completed a Clinical Residency at Emory University.
Through his 27 years in the profession of pharmacy, Robert has been involved in almost every facet of the industry. He has served as the Chief Clinical Pharmacist for a large metropolitan hospital, conducted clinical drug trials, consulted for three international pharmaceutical companies, and was a Vice President for an international healthcare company.
Robert is now the Executive Director of Medical Affairs for Gensco Laboratories.
LOOKING TO THE FUTURE
A single dose topical colchinium for acute gout flares.
A single dose topical anesthetic for injections and vaccines.
GENSCO® TRENDING
Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAPORT® (Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in development and commercialization of prescription more...
Looking To The Future
A single dose topical colchinium for acute gout flares.
- Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAPORT® (Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To more...
- A Case Study of Treatment of Recalcitrant Nonpressure Chronic Ulcers Using Astero Gel Topical Hydrogel with 4% Lidocaine for Autolytic Debridement and Pain Management November 13, 2017 Articles, Clinical, Featured, Research -
- An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years November 9, 2017 Clinical, Research -
